These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 27331856

  • 1. Palivizumab Adherence and Outcomes in Canadian Aboriginal Children.
    Hui C, Paes B, Papenburg J, Mitchell I, Li A, Lanctôt KL, CARESS Investigators.
    Pediatr Infect Dis J; 2016 Nov; 35(11):1187-1193. PubMed ID: 27331856
    [Abstract] [Full Text] [Related]

  • 2. Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017.
    Kim D, Saleem M, Paes B, Mitchell I, Lanctôt KL.
    Clin Infect Dis; 2019 Aug 30; 69(6):980-986. PubMed ID: 30517603
    [Abstract] [Full Text] [Related]

  • 3. Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.
    Paes B, Kim D, Saleem M, Wong S, Mitchell I, Lanctot KL, and the CARESS investigators.
    Eur J Pediatr; 2019 Mar 30; 178(3):377-385. PubMed ID: 30610419
    [Abstract] [Full Text] [Related]

  • 4. Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005-2017).
    Paes BA, Saleem M, Li A, Lanctôt KL, Mitchell I, CARESS Investigators.
    Pediatr Infect Dis J; 2020 Jun 30; 39(6):539-545. PubMed ID: 32235248
    [Abstract] [Full Text] [Related]

  • 5. Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab.
    Wang DY, Saleem M, Paes BA, Mitchell I, Li A, Lanctôt KL, CARESS Investigators.
    Pediatr Infect Dis J; 2019 Aug 30; 38(8):775-780. PubMed ID: 30985509
    [Abstract] [Full Text] [Related]

  • 6. Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab.
    Chan P, Li A, Paes B, Abraha H, Mitchell I, Lanctôt KL, CARESS investigators.
    Pediatr Infect Dis J; 2015 Dec 30; 34(12):e290-7. PubMed ID: 26780032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada.
    Mitchell I, Li A, Bjornson CL, Lanctot KL, Paes BA, CARESS investigators.
    Am J Perinatol; 2022 Nov 30; 39(15):1668-1677. PubMed ID: 33657636
    [Abstract] [Full Text] [Related]

  • 10. Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Bjornson C, Chan P, Li A, Paes B, Lanctôt KL, Mitchell I.
    Eur J Clin Microbiol Infect Dis; 2018 Jun 30; 37(6):1113-1118. PubMed ID: 29557081
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.
    Manzoni P, Paes B, Lanctôt KL, Dall'Agnola A, Mitchell I, Calabrese S, Maule M, Girardi E, Harimoto T, Li A.
    Pediatr Infect Dis J; 2017 Jan 30; 36(1):2-8. PubMed ID: 27649365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).
    Mitchell I, Wong SK, Paes B, Ruff M, Bjornson C, Li A, Lanctôt KL, CARESS investigators.
    Eur J Clin Microbiol Infect Dis; 2018 Jul 30; 37(7):1345-1352. PubMed ID: 29728782
    [Abstract] [Full Text] [Related]

  • 14. Respiratory syncytial virus (RSV) infection in children with medical complexity.
    Lim A, Butt ML, Dix J, Elliott L, Paes B.
    Eur J Clin Microbiol Infect Dis; 2019 Jan 30; 38(1):171-176. PubMed ID: 30374685
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR.
    Pediatr Infect Dis J; 2003 Feb 30; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.